UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000018165 |
|---|---|
| Receipt number | R000021029 |
| Scientific Title | Phase 2 study of trastuzumab and docetaxel therapy for HER2-positive recurrent/metastatic salivary gland carcinoma |
| Date of disclosure of the study information | 2015/07/06 |
| Last modified on | 2017/04/27 16:27:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/07/02 18:20:22 | ||
| 2 | Update | 2017/04/27 16:27:50 | Recruitment status |
